Hi Tehmina,
I see you have several posts in here going now. The most efficient way to communicate in here is to try for one post; you can add comments by typing a reply into the dialogue box below, then clicking the green ‘post comment’ button.
In another thread, you mentioned your mother’s viral load is ’25 lac’; this translates to 2.5 million (2,500,000) I believe. I assume the lab is using IU/mL for a unit measure?
Viral load is less important than genotype, which is the important predictor for treatment success. I commented in another thread about Infergen therapy; I’ll repost here:
~~~~~~~~~~~
Infergen/Consensus interferon is a possibility; although her odds of success are thought to be less than 32%, assuming her fibrosis is F1-F3: [Thanks Trish…]
“Patients achieving the greatest reduction in baseline viral load with peg-IFN/RBV therapy, especially in patients demonstrating > 1-log drop with initial therapy
Patients with fibrosis scores of F0 to F3 at baseline demonstrated SVRs of 7.8% in the 9 mcg arm and 13.1% in the 15 mcg arm
Patients maintaining full dose of INFERGEN/RBV therapy had SVRs of 7% and 17% for the 9 mcg and 15 mcg arms respectively
Patients demonstrating partial response (>2-log drop) with previous treatment and low fibrosis scores F0-F3 had SVRs of 10.7% and 31.6% for the 9 mcg and 15 mcg arms”
http://www.ncbi.nlm.nih.gov/pubmed/19291790?dopt=Abstract
~~~~~~~~~~~
You also received comments from others in the previous thread; here it is again in case you lost your way:
http://www.medhelp.org/posts/Hepatitis-C/need-help-to-take-decision-regarding-hep-c-treatment/show/1418446?personal_page_id=1931608#post_6466616
I agree with others that Vertex Pharmaceutical’s ‘Telaprevir’ offers her best chance to clear the virus; it will hopefully be available in the U.S. sometime next year. You should discuss this with your mother’s doctor; he might have insight as to when it will be available in your country.
Good luck to you and your family,
--Bill